Astec LifeSciences Limited (ASTEC.BO)
ASTEC.BO Stock Price Chart
Explore Astec LifeSciences Limited interactive price chart. Choose custom timeframes to analyze ASTEC.BO price movements and trends.
ASTEC.BO Company Profile
Discover essential business fundamentals and corporate details for Astec LifeSciences Limited (ASTEC.BO) to support your stock research and investment decisions.
Sector
Basic Materials
Industry
Agricultural Inputs
IPO Date
25 Nov 2009
Employees
606.00
Website
https://www.astecls.comCEO
Arijit Mukherjee
Description
Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemical active ingredients and pharmaceutical intermediates in India. Its products include triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic, aliphatic, and heterocyclic intermediates; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; heterocyclic mercaptans, thiopyrimidines, and aromatic mercaptans; heterocyclic sulfonyl chlorides, sulphonamides, and carbamates; thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. The company's products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.
ASTEC.BO Financial Timeline
Browse a chronological timeline of Astec LifeSciences Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 21 Apr 2026
Upcoming earnings on 26 Jan 2026
Upcoming earnings on 23 Oct 2025
Earnings released on 28 Jul 2025
EPS came in at -₹16.72 falling short of the estimated -₹9.70 by -72.39%, while revenue for the quarter reached ₹910.82M , missing expectations by -3.72%.
Earnings released on 23 Apr 2025
EPS came in at -₹8.20 surpassing the estimated -₹13.50 by +39.27%, while revenue for the quarter reached ₹1.20B , missing expectations by -21.33%.
Earnings released on 23 Jan 2025
EPS came in at -₹20.59 falling short of the estimated -₹16.98 by -21.29%, while revenue for the quarter reached ₹938.58M , missing expectations by -5.19%.
Earnings released on 25 Oct 2024
EPS came in at -₹19.66 falling short of the estimated -₹16.68 by -17.88%, while revenue for the quarter reached ₹985.46M , missing expectations by -26.07%.
Earnings released on 29 Jul 2024
EPS came in at -₹20.26 falling short of the estimated -₹8.74 by -131.88%, while revenue for the quarter reached ₹693.73M , missing expectations by -24.18%.
Earnings released on 2 May 2024
EPS came in at -₹0.50 falling short of the estimated -₹0.50 by -0.73%, while revenue for the quarter reached ₹1.54B , missing expectations by -0.29%.
Earnings released on 25 Jan 2024
EPS came in at -₹12.41 falling short of the estimated -₹12.01 by -3.31%, while revenue for the quarter reached ₹507.95M , missing expectations by -43.94%.
Earnings released on 28 Oct 2023
EPS came in at -₹6.85 falling short of the estimated -₹4.67 by -46.75%, while revenue for the quarter reached ₹1.11B , missing expectations by -9.93%.
Earnings released on 27 Jul 2023
EPS came in at -₹4.18 falling short of the estimated -₹2.28 by -83.05%, while revenue for the quarter reached ₹1.43B , missing expectations by -0.59%.
Dividend declared on 21 Jul 2023
A dividend of ₹1.50 per share was announced, adjusted to ₹1.50. The dividend was paid on 29 Jul 2023.
Earnings released on 2 May 2023
EPS came in at -₹2.54 falling short of the estimated ₹0.90 by -382.40%, while revenue for the quarter reached ₹1.27B , missing expectations by -21.62%.
Earnings released on 30 Jan 2023
EPS came in at ₹0.43 falling short of the estimated ₹5.30 by -91.92%, while revenue for the quarter reached ₹1.17B , missing expectations by -33.08%.
Earnings released on 30 Sept 2022
EPS came in at ₹9.34 surpassing the estimated ₹9.30 by +0.43%, while revenue for the quarter reached ₹2.00B , beating expectations by +1.14%.
Earnings released on 30 Jun 2022
EPS came in at ₹5.81 falling short of the estimated ₹10.70 by -45.70%, while revenue for the quarter reached ₹1.84B , beating expectations by +2.31%.
Earnings released on 31 Mar 2022
EPS came in at ₹21.96 surpassing the estimated ₹19.40 by +13.20%, while revenue for the quarter reached ₹2.72B , beating expectations by +8.53%.
Earnings released on 31 Dec 2021
EPS came in at ₹12.62 , while revenue for the quarter reached ₹1.73B .
Earnings released on 30 Sept 2021
EPS came in at ₹4.63 , while revenue for the quarter reached ₹1.03B .
Earnings released on 30 Jun 2021
EPS came in at ₹6.62 , while revenue for the quarter reached ₹1.29B .
Earnings released on 31 Mar 2021
EPS came in at ₹12.23 , while revenue for the quarter reached ₹1.72B .
Earnings released on 31 Dec 2020
EPS came in at ₹3.60 , while revenue for the quarter reached ₹1.16B .
Earnings released on 30 Sept 2020
EPS came in at ₹9.11 , while revenue for the quarter reached ₹1.55B .
ASTEC.BO Stock Performance
Access detailed ASTEC.BO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.